You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

MIGRANAL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Migranal, and what generic alternatives are available?

Migranal is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in MIGRANAL is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Migranal

A generic version of MIGRANAL was approved as dihydroergotamine mesylate by PADAGIS US on April 28th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MIGRANAL?
  • What are the global sales for MIGRANAL?
  • What is Average Wholesale Price for MIGRANAL?
Summary for MIGRANAL
Drug patent expirations by year for MIGRANAL
Drug Prices for MIGRANAL

See drug prices for MIGRANAL

Recent Clinical Trials for MIGRANAL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Impel NeuroPharma Inc.Phase 1
Stanford UniversityPhase 2
Thomas Jefferson UniversityPhase 4

See all MIGRANAL clinical trials

Pharmacology for MIGRANAL

US Patents and Regulatory Information for MIGRANAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MIGRANAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 ⤷  Sign Up ⤷  Sign Up
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 ⤷  Sign Up ⤷  Sign Up
Bausch MIGRANAL dihydroergotamine mesylate SPRAY, METERED;NASAL 020148-001 Dec 8, 1997 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MIGRANAL

See the table below for patents covering MIGRANAL around the world.

Country Patent Number Title Estimated Expiration
Luxembourg 84613 ⤷  Sign Up
New Zealand 203117 NASALLY APPLIED PHARMACEUTICAL COMPOSITIONS ⤷  Sign Up
Denmark 499477 ⤷  Sign Up
Finland 773376 ⤷  Sign Up
South Africa 8300673 ⤷  Sign Up
Philippines 23643 NASAL PHARMACEUTICAL COMPOSITION ⤷  Sign Up
Hungary 185924 PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL ADMINISTRATION CONTAINING ERGOT ALKALOIDS ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.